Hyperfine (NASDAQ:HYPR) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) Critical Comparison

Hyperfine (NASDAQ:HYPR) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Analyst Recommendations

This is a summary of current recommendations for Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hyperfine	0	1	0	0	2.00
Pheton Holdings Ltd Class A Ordinary Shares	0	0	0	0	0.00

Hyperfine presently has a consensus price target of $1.60, indicating a potential upside of 25.00%. Given Hyperfine’s stronger consensus rating and higher possible upside, analysts clearly believe Hyperfine is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.

Profitability

This table compares Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Hyperfine	-309.42%	-57.54%	-50.38%
Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A

Valuation and Earnings

This table compares Hyperfine and Pheton Holdings Ltd Class A Ordinary Shares”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hyperfine	$13.26 million	7.04	-$44.24 million	($0.57)	-2.25
Pheton Holdings Ltd Class A Ordinary Shares	$572,291.00	42.21	N/A	N/A	N/A

Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than Hyperfine.

Institutional & Insider Ownership

15.0% of Hyperfine shares are owned by institutional investors. 29.4% of Hyperfine shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Hyperfine beats Pheton Holdings Ltd Class A Ordinary Shares on 5 of the 9 factors compared between the two stocks.

About Hyperfine

Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.